Blog

Can Immunotherapy Bypass Sequential Care in RCC? – OncLive


OncLive

Can Immunotherapy Bypass Sequential Care in RCC?
OncLive
McDermott outlined the potential for immunotherapy in RCC at the 2nd Annual International Congress on Immunotherapies in Cancer™, hosted by Physicians' Education Resource®, LLC, in New York, New York, in December 2017. Despite positive clinical trial

2018-02-02 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.